BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, Schmitt HJ, Welte T. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med 2018;137:6-13. [PMID: 29605214 DOI: 10.1016/j.rmed.2018.02.007] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Feldman C, Shaddock E. Epidemiology of lower respiratory tract infections in adults. Expert Review of Respiratory Medicine 2018;13:63-77. [DOI: 10.1080/17476348.2019.1555040] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
2 Navarro-Torné A, Montuori EA, Kossyvaki V, Méndez C. Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis. Hum Vaccin Immunother 2021;17:3670-86. [PMID: 34106040 DOI: 10.1080/21645515.2021.1923348] [Reference Citation Analysis]
3 Høgli JU, Garcia BH, Svendsen K, Skogen V, Småbrekke L. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study. BMC Pulm Med 2020;20:169. [PMID: 32539706 DOI: 10.1186/s12890-020-01188-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Falcó V, Burgos J, Almirante B. An overview of lefamulin for the treatment of community acquired bacterial pneumonia. Expert Opin Pharmacother 2020;21:629-36. [PMID: 31958020 DOI: 10.1080/14656566.2020.1714592] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
5 Sallam M, Abbadi J, Natsheh A, Ababneh NA, Mahafzah A, Özkaya Şahin G. Trends in Antimicrobial Drug Resistance of Streptococcus pneumoniae Isolates at Jordan University Hospital (2000⁻2018). Antibiotics (Basel) 2019;8:E41. [PMID: 31013803 DOI: 10.3390/antibiotics8020041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ecarnot F, Pedone C, Cesari M, Maggi S, Antonelli Incalzi R. Knowledge about vaccines and vaccination in older people: Results of a national survey by the Italian Society for Gerontology & Geriatrics. Vaccine 2020;38:1535-40. [PMID: 31822428 DOI: 10.1016/j.vaccine.2019.11.065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Hyams C, Begier E, Garcia Gonzalez M, Southern J, Campling J, Gray S, Oliver J, Gessner BD, Finn A. Incidence of acute lower respiratory tract disease hospitalisations, including pneumonia, among adults in Bristol, UK, 2019, estimated using both a prospective and retrospective methodology. BMJ Open 2022;12:e057464. [PMID: 35705333 DOI: 10.1136/bmjopen-2021-057464] [Reference Citation Analysis]
8 Liapikou A, Cilloniz C, Palomeque A, Torres T. Emerging antibiotics for community-acquired pneumonia. Expert Opin Emerg Drugs 2019;24:221-31. [PMID: 31657962 DOI: 10.1080/14728214.2019.1685494] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
9 Ding H, Huang J, Ngai CH, Sun Q, Kwok K, Wang HH, Chong M, Wong MC. The cost-effectiveness of starting 23-valent pneumococcal polysaccharide vaccine and influenza vaccination at 50 vs. 65 years: A comparative modelling study. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.01.033] [Reference Citation Analysis]
10 Torén K, Blanc PD, Naidoo R, Murgia N, Stockfelt L, Schiöler L. Cumulative occupational exposure to inorganic dust and fumes and invasive pneumococcal disease with pneumonia. Int Arch Occup Environ Health 2022. [PMID: 35262802 DOI: 10.1007/s00420-022-01848-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Astengo M, Paganino C, Amicizia D, Trucchi C, Tassinari F, Sticchi C, Sticchi L, Orsi A, Icardi G, Piazza MF, Di Silverio B, Deb A, Senese F, Prandi GM, Ansaldi F. Economic Burden of Pneumococcal Disease in Individuals Aged 15 Years and Older in the Liguria Region of Italy. Vaccines (Basel) 2021;9:1380. [PMID: 34960127 DOI: 10.3390/vaccines9121380] [Reference Citation Analysis]
12 Vila-Corcoles A, Ochoa-Gondar O, Vila-Rovira A, Aragon M, Esteban-Julvez L, Chamorro N, Hospital I, Satue E, Blade J, de Diego C, Gomez-Bertomeu F, Raga X. Incidence and Risk of Pneumococcal Pneumonia in Adults with Distinct Underlying Medical Conditions: A Population-Based Study. Lung 2020;198:481-9. [PMID: 32253492 DOI: 10.1007/s00408-020-00349-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
13 Figueiredo DB, Kaneko K, Rodrigues TDC, MacLoughlin R, Miyaji EN, Saleem I, Gonçalves VM. Pneumococcal Surface Protein A-Hybrid Nanoparticles Protect Mice from Lethal Challenge after Mucosal Immunization Targeting the Lungs. Pharmaceutics 2022;14:1238. [PMID: 35745810 DOI: 10.3390/pharmaceutics14061238] [Reference Citation Analysis]
14 Cillóniz C, Rodríguez-Hurtado D, Torres A. Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging. Med Sci (Basel) 2018;6:E35. [PMID: 29710871 DOI: 10.3390/medsci6020035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
15 Menéndez R, Cilloniz C, España PP, Almirall J, Uranga A, Méndez R, Rigau D, Torres A. Community-Acquired Pneumonia. Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) Guidelines. 2020 Update. Arch Bronconeumol 2020;56 Suppl 1:1-10. [PMID: 32139236 DOI: 10.1016/j.arbres.2020.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
16 Walkowski W, Bassett J, Bhalla M, Pfeifer BA, Ghanem ENB. Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease. Vaccines (Basel) 2021;9:589. [PMID: 34199398 DOI: 10.3390/vaccines9060589] [Reference Citation Analysis]
17 Lopez-de-Andres A, Jimenez-Garcia R, Hernandez-Barrera V, de Miguel-Diez J, de Miguel-Yanes JM, Carabantes-Alarcon D, Zamorano-Leon JJ, Sanz-Rojo S, Lopez-Herranz M. Sex-Related Disparities in the Incidence and Outcomes of Community-Acquired Pneumonia among Type 2 Diabetes Patients: A Propensity Score-Matching Analysis Using the Spanish National Hospital Discharge Database for the Period 2016-2019. J Clin Med 2021;10:3975. [PMID: 34501421 DOI: 10.3390/jcm10173975] [Reference Citation Analysis]
18 McCurdy SP, Sheets AJ, Cammarata SK, Vidal JE. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae isolates from a Phase III community-acquired bacterial pneumonia (CABP) trial. JAC Antimicrob Resist 2021;3:dlab057. [PMID: 34223119 DOI: 10.1093/jacamr/dlab057] [Reference Citation Analysis]
19 Chen L, Kraft BD, Roggli VL, Healy ZR, Woods CW, Tsalik EL, Ginsburg GS, Murdoch DM, Suliman HB, Piantadosi CA, Welty-Wolf KE. Heparin-based blood purification attenuates organ injury in baboons with Streptococcus pneumoniae pneumonia. Am J Physiol Lung Cell Mol Physiol 2021;321:L321-35. [PMID: 34105359 DOI: 10.1152/ajplung.00337.2020] [Reference Citation Analysis]
20 Rejas J, Sicras-Mainar A, Sicras-Navarro A, Lwoff N, Méndez C. All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain. Expert Rev Pharmacoecon Outcomes Res 2021. [PMID: 34949148 DOI: 10.1080/14737167.2022.2020649] [Reference Citation Analysis]
21 Leblanc JJ, Elsherif M, Ye L, Mackinnon-cameron D, Ambrose A, Hatchette TF, Lang AL, Gillis HD, Martin I, Demczuk WH, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, Mccarthy AE, Mcgeer A, Semret M, Trottier S, Valiquette L, Webster D, Mcneil SA. Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assay. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.02.081] [Reference Citation Analysis]
22 Loubet P, Rouvière J, Merceron A, Launay O, Sotto A, On Behalf Of The Avnir Group. Patients' Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections. Vaccines (Basel) 2021;9:1372. [PMID: 34835303 DOI: 10.3390/vaccines9111372] [Reference Citation Analysis]
23 Theilacker C, Sprenger R, Leverkus F, Walker J, Häckl D, von Eiff C, Schiffner-Rohe J. Population-based incidence and mortality of community-acquired pneumonia in Germany. PLoS One 2021;16:e0253118. [PMID: 34129632 DOI: 10.1371/journal.pone.0253118] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Feldman C, Anderson R. Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients With Community-Acquired Pneumonia. Front Immunol 2020;11:577303. [PMID: 33042161 DOI: 10.3389/fimmu.2020.577303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ho J, Ip M. Antibiotic-Resistant Community-Acquired Bacterial Pneumonia. Infect Dis Clin North Am 2019;33:1087-103. [PMID: 31668192 DOI: 10.1016/j.idc.2019.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
26 Dupuis C, Sabra A, Patrier J, Chaize G, Saighi A, Féger C, Vainchtock A, Gaillat J, Timsit JF. Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs. Crit Care 2021;25:24. [PMID: 33423691 DOI: 10.1186/s13054-020-03442-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Root-Bernstein R. Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines (Basel) 2021;9:474. [PMID: 34066697 DOI: 10.3390/vaccines9050474] [Reference Citation Analysis]
28 Gajewska M, Goryński P, Paradowska-Stankiewicz I, Lewtak K, Piotrowicz M, Urban E, Cianciara D, Wysocki MJ, Książek A, Izurieta P. Monitoring of community-acquired pneumonia hospitalisations before the introduction of pneumococcal conjugate vaccine into Polish National Immunisation Programme (2009-2016): A nationwide retrospective database analysis. Vaccine 2020;38:194-201. [PMID: 31653527 DOI: 10.1016/j.vaccine.2019.10.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 Feldman C, Normark S, Henriques‐normark B, Anderson R. Pathogenesis and prevention of risk of cardiovascular events in patients with pneumococcal community‐acquired pneumonia. J Intern Med 2019;285:635-52. [DOI: 10.1111/joim.12875] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
30 Cools F, Torfs E, Aizawa J, Vanhoutte B, Maes L, Caljon G, Delputte P, Cappoen D, Cos P. Optimization and Characterization of a Galleria mellonella Larval Infection Model for Virulence Studies and the Evaluation of Therapeutics Against Streptococcus pneumoniae. Front Microbiol 2019;10:311. [PMID: 30846978 DOI: 10.3389/fmicb.2019.00311] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
31 Grant LR, Slack MPE, Yan Q, Trzciński K, Barratt J, Sobczyk E, Appleby J, Cané A, Jodar L, Isturiz RE, Gessner BD. The epidemiologic and biologic basis for classifying older age as a high-risk, immunocompromising condition for pneumococcal vaccine policy. Expert Rev Vaccines 2021;20:691-705. [PMID: 34233558 DOI: 10.1080/14760584.2021.1921579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Salvador M, Marqués-Fernández JL, Bunge A, Martínez-García JC, Turcu R, Peddis D, García-Suárez MDM, Cima-Cabal MD, Rivas M. Magnetic Nanoclusters Increase the Sensitivity of Lateral Flow Immunoassays for Protein Detection: Application to Pneumolysin as a Biomarker for Streptococcus pneumoniae. Nanomaterials (Basel) 2022;12:2044. [PMID: 35745381 DOI: 10.3390/nano12122044] [Reference Citation Analysis]
33 Vargas-zabala DL, Cabrera-velasco C, Lozano-fernandez V, Cardeño-sanchez J, Vargas-uricoechea H. Perfil microbiologico y de resistencia antimicrobiana en infecciones adquiridas en la comunidad. Hospital Universitario San José de Popayán. Infect 2020;25:39. [DOI: 10.22354/in.v25i1.907] [Reference Citation Analysis]
34 Vázquez R, García E, García P. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials. Front Immunol 2018;9:2252. [PMID: 30459750 DOI: 10.3389/fimmu.2018.02252] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 8.3] [Reference Citation Analysis]
35 Martin-Loeches I, Torres A. New guidelines for severe community-acquired pneumonia. Curr Opin Pulm Med 2021;27:210-5. [PMID: 33405483 DOI: 10.1097/MCP.0000000000000760] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Gouveia M, Jesus G, Inês M, Costa J, Borges M. Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine. Hum Vaccin Immunother 2019;15:850-8. [PMID: 30633615 DOI: 10.1080/21645515.2018.1560769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 LeBlanc J, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, Lang AL, Gillis HD, Martin I, Demczuk WH, LaFerriere C, Andrew MK, Boivin G, Bowie W, Green K, Johnstone J, Loeb M, McCarthy A, McGeer A, Semret M, Trottier S, Valiquette L, Webster D, McNeil SA. Age-stratified burden of pneumococcal community acquired pneumonia in hospitalised Canadian adults from 2010 to 2015. BMJ Open Respir Res 2020;7:e000550. [PMID: 32188585 DOI: 10.1136/bmjresp-2019-000550] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
38 García-Suárez MDM, González-Rodríguez I, Cima-Cabal MD, Yuste JE, Vazquez F, Santiago E. Identification of Pneumococcal Serotypes by PCR-Restriction Fragment Length Polymorphism. Diagnostics (Basel) 2019;9:E196. [PMID: 31752204 DOI: 10.3390/diagnostics9040196] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Lan S, Lai C, Chang S, Lu L, Hung S, Lin W. Five-day antibiotic treatment for community-acquired bacterial pneumonia: A systematic review and meta-analysis of randomized controlled trials. Journal of Global Antimicrobial Resistance 2020;23:94-9. [DOI: 10.1016/j.jgar.2020.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Blanc E, Chaize G, Fievez S, Féger C, Herquelot E, Vainchtock A, Timsit JF, Gaillat J. The impact of comorbidities and their stacking on short- and long-term prognosis of patients over 50 with community-acquired pneumonia. BMC Infect Dis 2021;21:949. [PMID: 34521380 DOI: 10.1186/s12879-021-06669-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
41 Murdaca G, Noberasco G, Olobardi D, Lunardi C, Maule M, Delfino L, Triggiani M, Cardamone C, Benfaremo D, Moroncini G, Vacca A, Susca N, Gangemi S, Quattrocchi P, Sticchi L, Icardi G, Orsi A. Current Take on Systemic Sclerosis Patients' Vaccination Recommendations. Vaccines (Basel) 2021;9:1426. [PMID: 34960174 DOI: 10.3390/vaccines9121426] [Reference Citation Analysis]
42 Torén K, Blanc PD, Naidoo RN, Murgia N, Qvarfordt I, Aspevall O, Dahlman-Hoglund A, Schioler L. Occupational exposure to dust and to fumes, work as a welder and invasive pneumococcal disease risk. Occup Environ Med 2020;77:57-63. [PMID: 31848233 DOI: 10.1136/oemed-2019-106175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
43 Ramos-Rincón JM, Pinargote-Celorio H, Belinchón-Romero I, González-Alcaide G. A snapshot of pneumonia research activity and collaboration patterns (2001-2015): a global bibliometric analysis. BMC Med Res Methodol 2019;19:184. [PMID: 31488065 DOI: 10.1186/s12874-019-0819-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Costa MI, Cipriano A, Santos FV, Valdoleiros SR, Furtado I, Machado A, Abreu M, Bastos HN. Clinical profile and microbiological aetiology diagnosis in adult patients hospitalized with community-acquired pneumonia. Pulmonology 2020:S2531-0437(20)30246-4. [PMID: 33358259 DOI: 10.1016/j.pulmoe.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Briestenská K, Mikušová M, Tomčíková K, Kostolanský F, Varečková E. Quantification of bacteria by in vivo bioluminescence imaging in comparison with standard spread plate method and reverse transcription quantitative PCR (RT-qPCR). Arch Microbiol 2021;203:4737-42. [PMID: 34184097 DOI: 10.1007/s00203-021-02458-5] [Reference Citation Analysis]
46 Torén K, Blanc PD, Qvarfordt I, Aspevall O, Schiöler L. Inhaled Corticosteroids Use and Risk of Invasive Pneumococcal Disease in a Population-based Study. Ann Am Thorac Soc 2020;17:1570-5. [PMID: 32649216 DOI: 10.1513/AnnalsATS.202004-352OC] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Debray MP, Carette MF, Loubet P, Pasquet B, Houhou Fidouh N, Benjoar M, Varon E, Brun AL, Claessens YE, Duval X, Khalil A; ESCAPED study group. CT features of community-acquired pneumonia at the emergency department. Respir Med Res 2022;81:100892. [PMID: 35489109 DOI: 10.1016/j.resmer.2022.100892] [Reference Citation Analysis]
48 Horn KJ, Jaberi Vivar AC, Arenas V, Andani S, Janoff EN, Clark SE. Corynebacterium Species Inhibit Streptococcus pneumoniae Colonization and Infection of the Mouse Airway. Front Microbiol 2021;12:804935. [PMID: 35082772 DOI: 10.3389/fmicb.2021.804935] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Feldman C, Anderson R. Recent advances in the epidemiology and prevention of Streptococcus pneumoniae infections. F1000Res 2020;9:F1000 Faculty Rev-338. [PMID: 32411353 DOI: 10.12688/f1000research.22341.1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
50 de-Miguel-Díez J, López-de-Andrés A, Hernández-Barrera V, de-Miguel-Yanes JM, Carabantes-Alarcón D, Ji Z, Zamorano-Leon JJ, Jiménez-García R. Sex-differences in incidence of hospitalizations and in hospital mortality of community-acquired pneumonia among children in Spain: a population-based study. Eur J Pediatr 2022. [PMID: 35469030 DOI: 10.1007/s00431-022-04478-9] [Reference Citation Analysis]